0000899243-19-025027.txt : 20191003
0000899243-19-025027.hdr.sgml : 20191003
20191003204022
ACCESSION NUMBER: 0000899243-19-025027
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191001
FILED AS OF DATE: 20191003
DATE AS OF CHANGE: 20191003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Revesz Tomas Jr
CENTRAL INDEX KEY: 0001744802
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38549
FILM NUMBER: 191137338
MAIL ADDRESS:
STREET 1: 210 BROADWAY
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EverQuote, Inc.
CENTRAL INDEX KEY: 0001640428
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
IRS NUMBER: 263101161
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 210 BROADWAY
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-245-0615
MAIL ADDRESS:
STREET 1: 210 BROADWAY
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-10-01
0
0001640428
EverQuote, Inc.
EVER
0001744802
Revesz Tomas Jr
C/O EVERQUOTE, INC.
210 BROADWAY
CAMBRIDGE
MA
02139
0
1
0
0
Chief Technology Officer
Class A Common Stock
2019-10-01
4
S
0
7907
20.88
D
617093
D
Class A Common Stock
2019-10-01
4
S
0
5000
20.88
D
612093
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2019. The sales do not represent a discretionary trade by the reporting person.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2019 and represent the sale of shares necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 28, 2019.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.24 to $21.46, inclusive. The reporting person undertakes to provide to EverQuote, Inc., any security holder of EverQuote, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
/s/ David Mason, as attorney-in-fact for Tomas Revesz
2019-10-03